Latest News

  • MRD Futures for Pharma

    Diagnostics World | Minimal residual disease testing (MRD) has been gaining ground in diagnostics, and a panel took on the topic at the Precision Medicine TriCon late last month.

    Apr 17, 2024

  • Age of Opportunity: Artificial Intelligence and the Precision Medicine Future

    Diagnostics World | At the Precision Med TriConference 2024, Illumina Ventures partner Mara Aspinall sat with Eric Topol, endowed chair and executive VP and professor at Scripps Translational Science Institute, in a fireside chat to discuss precision medicine and artificial intelligence (AI). With three published books and more than 1,200 peer reviewed publications, Topol is one of the industry’s leading minds on digital medicine, and from his perspective, AI needs to be adapted sooner.

    Apr 16, 2024

  • New Cortisol Analysis Test Offers Faster, More Accurate Diagnosis

    Diagnostics World | As the body’s stress hormone, cortisol influences several diseases, from chronic illnesses, such as diabetes and cancer; to mental illnesses, such as depression; to neurological diseases, such as Alzheimer’s disease. Researchers at Aarhus University have discovered a breakthrough method to measure cortisol in an efficient, faster way.

    Apr 11, 2024

  • NVIDIA GTC Panel Explores the Role of Generative AI in Medicine

    Diagnostics World | During the NVIDIA GTC conference held at the San Jose Convention Center and online March 18-21, NVIDIA CEO Jensen Huang highlighted an array of advancements, including new foundation models coming to NVIDIA BioNeMo, a collaboration with Johnson & Johnson MedTech to expand AI’s role in surgical settings, and the launch of over two dozen generative AI microservices to advance areas like digital health, medical technology, and drug discovery.

    Apr 9, 2024

  • Time-Of-Day Activity Levels Linked To Amyloid Deposits In The Brain

    Diagnostics World | A wearable device measuring movement at the wrist can detect clear differences in people who do and don’t have beta-amyloid deposition in their brain. The discovery was enabled by a relatively new statistical technique revealing time-of-day changes in activity levels not captured by standard methods focused on average levels of activity across the day.

    Apr 4, 2024

  • EEG Monitoring Concerningly Underutilized In Clinical Trials

    Diagnostics World | Study sponsors making choices about if, when, and how to include brain monitoring in their clinical studies do not often ground those choices in science or optimize for subject safety and trial de-risking. The key problem is a lack of electroencephalogram (EEG) expertise with no guidance from the Food and Drug Administration (FDA) to mitigate the situation.

    Apr 3, 2024